1646MO Phase II ATLEP trial: Final results for lenvatinib/pembrolizumab in metastasized anaplastic and poorly differentiated thyroid carcinoma

Authors:
  • CDC. Dierks
    C. Dierks
  • JRJ. Ruf
    J. Ruf
  • JSJ. Seufert
    J. Seufert
  • MKM. Kreissl
    M. Kreissl
  • CKC. Klein
    C. Klein
  • CSC. Spitzweg
    C. Spitzweg
  • MKM. Kroiss
    M. Kroiss
  • OTO. Thomusch
    O. Thomusch
  • KLK. Lorenz
    K. Lorenz
  • AZA. Zielke
    A. Zielke
  • CMC. Miething
    C. Miething

Abstract
No abstract available